Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 17;5(1):9.
doi: 10.3390/jof5010009.

New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies

Thomas F Patterson  1 , J Peter Donnelly  2
Affiliations
Review

New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies

Thomas F Patterson et al. J Fungi (Basel). .

Abstract

Non-culture-based diagnostics have been developed to help establish an early diagnosis of invasive fungal infection. Studies have shown that these tests can significantly impact the diagnosis of infection in high risk patients. Aspergillus galactomannan EIA testing is well-recognized as an important adjunct to the diagnosis of invasive aspergillosis and can be detected in serum, bronchoalveolar lavage and other fluids. Galactomannan testing used along with PCR testing has been shown to be effective when integrated into care paths for high risk patients for both diagnoses and as a surrogate marker for outcome when used in serial testing. Beta-d-glucan assays are non-specific for several fungal genera including Aspergillus and Candida and in high risk patients have been an important tool to augment the diagnosis. Lateral flow technology using monoclonal antibodies to Aspergillus are available that allow rapid testing of clinical samples. While standard PCR for Candida remains investigational, T2 magnetic resonance allows for the rapid diagnosis of Candida species from blood cultures. Aspergillus PCR has been extensively validated with standardized approaches established for these methods and will be included in the diagnostic criteria in the revised European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC-MSG) definitions. Finally, these non-culture-based tests can be used in combination to significantly increase the detection of invasive mycoses with the ultimate aim of establishing an early diagnosis of infection.

Keywords: Aspergillus PCR; T2 Candida; aspergillosis; beta-d-glucan; candidiasis; galactomannan; invasive fungal infection; lateral flow; non-culture-based diagnostics.

PubMed Disclaimer

Conflict of interest statement

For activities outside of the submitted work, T.F.P. has been a consultant for or served on advisory boards to Astellas, Basilea, Gilead, Merck, Pfizer, Scynexis, and Toyama. J.P.D is a member of the European Aspergillus PCR initiative (EAPCRI).

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mikulska M., Furfaro E., Viscoli C. Non-cultural methods for the diagnosis of invasive fungal disease. Expert Rev. Anti Infect. Ther. 2015;13:103–117. doi: 10.1586/14787210.2015.979788. - DOI - PubMed
    1. Hope W.W., Walsh T.J., Denning D.W. Laboratory diagnosis of invasive aspergillosis. Lancet Infect. Dis. 2005;5:609–622. doi: 10.1016/S1473-3099(05)70238-3. - DOI - PubMed
    1. Baldin C., Soliman S.S.M., Jeon H.H., Alkhazraji S., Gebremariam T., Gu Y., Bruno V.M., Cornely O.A., Leather H.L., Sugrue M.W., et al. Pcr-based approach targeting mucorales-specific gene family for diagnosis of mucormycosis. J. Clin. Microbiol. 2018;56 doi: 10.1128/JCM.00746-18. - DOI - PMC - PubMed
    1. Scherer E., Iriart X., Bellanger A.P., Dupont D., Guitard J., Gabriel F., Cassaing S., Charpentier E., Guenounou S., Cornet M., et al. Quantitative pcr (qpcr) detection of mucorales DNA in bronchoalveolar lavage fluid to diagnose pulmonary mucormycosis. J. Clin. Microbiol. 2018;56 doi: 10.1128/JCM.00289-18. - DOI - PMC - PubMed
    1. Herbrecht R., Bories P., Moulin J.C., Ledoux M.P., Letscher-Bru V. Risk stratification for invasive aspergillosis in immunocompromised patients. Ann. N. Y. Acad. Sci. 2012;1272:23–30. doi: 10.1111/j.1749-6632.2012.06829.x. - DOI - PubMed

LinkOut - more resources